Device recall: STA - Deficient VIII, Product Code: 00725. STA - Deficient VIII is an immuno-depleted human plasma intended for use in…

Class II FDA enforcement event 85167. Recall start date: 4 Mar 2020. Status in the FDA record: Terminated. Termination date: 10 Nov 2021.

Reason for recall, in the words of FDA

A risk of sample-to-sample cross-contamination of Emicizumab for factor VIII assays on Stago instruments, clotting times will be shortened that may cause factor VIII levels reported to be falsely increased

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Diagnostica Stago, Inc. started this device recall on 4 Mar 2020. The firm address in the FDA record is in Parsippany, NJ. FDA put the recall in Class II. FDA event 85167 has 1 product record. The first FDA enforcement report date is 22 Apr 2020. The record gives the status Terminated, with the termination date 10 Nov 2021.

FDA enforcement report The 1 product record

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.
FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on 1 Oct 2026. openFDA export of 28 Sep 2026.

Distribution

In the words of FDA.

Nationwide

Recalling firm

Diagnostica Stago, Inc., Parsippany, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 85167: product records
Recall number	Product	Quantity	Class	Status	Report date
Z-1699-2020	STA - Deficient VIII, Product Code: 00725. STA - Deficient VIII is an immuno-depleted human plasma intended for use in tests for the determination of factor VIII activity in plasma on STA-R and STA Compact analyzer platforms as follows: (A) STA-R Max, Product Codes: 58989, 58990 (B) STA-R Evolution, Product Codes:…	3,225 units	Class II	Terminated	22 Apr 2020

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2020: 916
Share of these events in Class II: 93%
Product records in this event: 1Median of the firm: 1
Events of the firm on the register: 16

Other events of the firm

Other FDA enforcement events of Diagnostica Stago, Inc.
Initiated	Product (first record)	Type	Class	Records
29 Jul 2026	STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor defici	Device	Class II	1
5 Feb 2026	Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF 00515 Product Description: in vitr	Device	Class II	1
4 Feb 2026	Brand Name: STA Liatest Free Protein S Product Name: STA Liatest Free Protein S Model/Catalog Number (REF): 00516 Produc	Device	Class II	1
15 Dec 2025	Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in pla	Device	Class II	1
12 Sep 2025	Product: STA Liatest D-Di; REF: 00515;	Device	Class II	1
21 Jul 2025	STA Satellite. Product Code: All references. All software versions. The STA Satellite is a fully automated benchtop anal	Device	Class II	4
21 May 2025	STA - Owren Koller. Model/Catalog Number: 00360 STA - Owren-Koller is a buffer solution intended for use as a diluent fo	Device	Class II	1
22 Mar 2023	STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 59	Device	Class II	3
18 Nov 2019	STA UNICALIBRATOR (ref. 00675)	Device	Class II	2
14 Nov 2018	Staclot LA (REF 00600) The Staclot LA and Staclot LA 20 test kits are reagent systems designed for the qualitative detec	Device	Class II	2

Diagnostica Stago, Inc.: all 16 events

Official channels

FDA enforcement report Z-1699-2020The FDA record of the first product of this event.
FDA: recalls, market withdrawals and safety alertsThe recall notices on the FDA site.
FDA MedWatchThe FDA safety reporting program for drugs and medical devices.

Follow by RSS:Food, drug and device recallsFDA Class I recalls

Cite this page

Recall Register. FDA enforcement event 85167. https://recallregister.com/fda/ii/85167/. Source: openFDA enforcement reports. Data through 28 Sep 2026.

Sources

Source: openFDA device enforcement reports
Licence: CC0 1.0
Export date: 28 Sep 2026
Newest FDA report date on the register: 23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?: The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 85167?: The FDA record gives this quantity: 3,225 units
How did the recall start?: The FDA record says: Voluntary: Firm initiated
How many device recalls of 2020 have the same class?: 93% of the 916 device events that started in 2020 are in Class II.